Heren Health Co.,Ltd. (SHE:300550)
13.95
+0.10 (0.72%)
At close: Oct 9, 2026
Heren Health Revenue
Heren Health had revenue of 81.69M CNY in the quarter ending June 30, 2026, with 1.50% growth. This brings the company's revenue in the last twelve months to 433.88M, up 7.28% year-over-year. In the year 2025, Heren Health had annual revenue of 435.06M with 7.15% growth. That makes Heren Health the 25,976th largest company in the world by revenue and 4,596th in China.
Revenue (ttm)
433.88M
Revenue Growth
+7.28%
P/S Ratio
8.44
Revenue / Employee
546.45K
Employees
794
Market Cap
3.66B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 435.06M | 29.04M | 7.15% |
| Dec 31, 2024 | 406.01M | -33.24M | -7.57% |
| Dec 31, 2023 | 439.25M | 78.92M | 21.90% |
| Jan 1, 2023 | 360.33M | -103.87M | -22.38% |
| Jan 1, 2022 | 464.20M | 9.46M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 51.52B |
| Shenzhen Mindray Bio-Medical Electronics | 34.29B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 31.32B |
| Sichuan Biokin Pharmaceutical | 2.54B |
| Xiangxue Pharmaceutical | 1.48B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Berry Genomics Co.,Ltd | 929.15M |
| Thalys Medical Technology Group | 836.23M |